WDNA vs. ACLO

Last updated Jun 21, 2026

WDNA (WisdomTree BioRevolution Fund) and ACLO (TCW AAA CLO ETF) are both exchange-traded funds - WDNA is a Health & Biotech Equities fund tracking the WisdomTree BioRevolution Index, while ACLO is a CLO fund actively managed by TCW. WDNA is passively managed, while ACLO is actively managed. Over the past year, WDNA returned 47.77% vs 5.31% for ACLO. At a correlation of -0.03, they often move in opposite directions. WDNA charges 0.45%/yr vs 0.20%/yr for ACLO.

Performance

WDNA vs. ACLO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and TCW AAA CLO ETF (ACLO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, WDNA achieves a 11.77% return, which is significantly higher than ACLO's 2.41% return.

WDNA

• 1D: 0.51%
• 1M: 7.43%
• YTD: 11.77%
• 6M: 11.01%
• 1Y: 47.77%
• 3Y*: 3.81%
• 5Y*: -4.95%
• 10Y*: —

ACLO

• 1D: 0.09%
• 1M: 0.41%
• YTD: 2.41%
• 6M: 2.54%
• 1Y: 5.31%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

WDNA vs. ACLO - Yearly Performance Comparison

	2026 (YTD)	2025	2024
WDNA WisdomTree BioRevolution Fund	11.77%	22.68%	-2.13%
ACLO TCW AAA CLO ETF	2.41%	5.32%	0.81%

Correlation

The correlation between WDNA and ACLO is -0.13, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.13
Correlation (All Time) Calculated using the full available price history since Nov 18, 2024	-0.03

The correlation between WDNA and ACLO shifts across timeframes, from -0.13 (1 year) to -0.03 (all time), reflecting how their relationship changes across market environments.

Return for Risk

WDNA vs. ACLO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WDNA

WDNA Risk / Return Rank: 59
WDNA Sharpe Ratio Rank: 56
WDNA Sortino Ratio Rank: 57
WDNA Omega Ratio Rank: 48
WDNA Calmar Ratio Rank: 80
WDNA Martin Ratio Rank: 54

ACLO

ACLO Risk / Return Rank: 99
ACLO Sharpe Ratio Rank: 99
ACLO Sortino Ratio Rank: 99
ACLO Omega Ratio Rank: 99
ACLO Calmar Ratio Rank: 99
ACLO Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WDNA vs. ACLO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and TCW AAA CLO ETF (ACLO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	WDNA	ACLO	Difference
Sharpe ratio: Return per unit of total volatility	1.80	7.36	-5.55
Sortino ratio: Return per unit of downside risk	2.62	15.22	-12.61
Omega ratio: Gain probability vs. loss probability	1.30	3.45	-2.15
Calmar ratio: Return relative to maximum drawdown	4.00	19.99	-15.99
Martin ratio: Return relative to average drawdown	8.96	166.22	-157.26

WDNA vs. ACLO - Sharpe Ratio Comparison

The current WDNA Sharpe Ratio is 1.80, which is lower than the ACLO Sharpe Ratio of 7.36. The chart below compares the historical Sharpe Ratios of WDNA and ACLO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

WDNA vs. ACLO - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, which is greater than ACLO's maximum drawdown of -1.01%. Use the drawdown chart below to compare losses from any high point for WDNA and ACLO.

Drawdown Indicators

	WDNA	ACLO	Difference
Max Drawdown Largest peak-to-trough decline	-58.87%	-1.01%	-57.86%
Max Drawdown (1Y) Largest decline over 1 year	-11.70%	-0.27%	-11.43%
Max Drawdown (3Y) Largest decline over 3 years	-38.25%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-58.87%	—	—
Current Drawdown Current decline from peak	-28.06%	0.00%	-28.06%
Average Drawdown Average peak-to-trough decline	-35.58%	-0.04%	-35.54%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.21%	0.03%	+5.18%

Volatility

WDNA vs. ACLO - Volatility Comparison

WisdomTree BioRevolution Fund (WDNA) has a higher volatility of 7.66% compared to TCW AAA CLO ETF (ACLO) at 0.19%. This indicates that WDNA's price experiences larger fluctuations and is considered to be riskier than ACLO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WDNA	ACLO	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.66%	0.19%	+7.47%
Volatility (6M) Calculated over the trailing 6-month period	17.00%	0.58%	+16.42%
Volatility (1Y) Calculated over the trailing 1-year period	25.91%	0.73%	+25.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.13%	1.07%	+24.06%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.08%	1.07%	+24.01%

WDNA vs. ACLO - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is higher than ACLO's 0.20% expense ratio.

Dividends

WDNA vs. ACLO - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 4.09%, less than ACLO's 4.90% yield.

Position	TTM	2025	2024	2023	2022	2021
ACLO TCW AAA CLO ETF	4.90%	4.87%	0.59%	0.00%	0.00%	0.00%
WDNA WisdomTree BioRevolution Fund	4.09%	4.57%	0.75%	0.80%	0.38%	0.10%

Frequently Asked Questions

Can I hold both WDNA and ACLO in my portfolio?

WDNA and ACLO have a correlation of -0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, WDNA or ACLO?

WDNA has higher volatility (7.66%) compared to ACLO (0.19%). In terms of maximum drawdown, WDNA dropped -58.87% vs ACLO's -1.01%.

Which ETF is better, WDNA or ACLO?

On 1-year performance, WDNA leads with 47.77% vs 5.31% for ACLO. On fees, ACLO is cheaper at 0.20% per year. On volatility, ACLO has been the lower-risk option at 0.19%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, WDNA or ACLO?

Over the 1-year period, WDNA has performed better with a 47.77% return vs 5.31%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, WDNA or ACLO?

ACLO is cheaper with a 0.20% expense ratio, compared with 0.45% for WDNA.

Which ETF pays a higher dividend yield, WDNA or ACLO?

ACLO has the higher dividend yield at 4.90%, compared with 4.09% for WDNA.

What is the main difference between WDNA and ACLO?

WDNA is categorized as Health & Biotech Equities, while ACLO is CLO. They also come from different issuers: WisdomTree and TCW. Their fees differ too: 0.45% for WDNA and 0.20% for ACLO.

Which has better risk-adjusted returns?

ACLO currently has the higher Sharpe Ratio (7.36 vs 1.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.